Search

Author/Creator Ryan, Christopher

1. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020)

Authors:
Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020)

Authors:
Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). (9th November 2020)

Authors:
Wagner, Michael; Othus, Megan; Patel, Sandip; Ryan, Christopher; Sangal, Ashish; Powers, Benjamin; Budd, George; Victor, Adrienne; Hsueh, Chung-Tsen; Chugh, Rashmi; Nair, Suresh; Leu, Kirsten; Agulnik, Mark; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Blanke, Charles; Streicher, Howard; Chae,...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A475
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). (9th November 2020)

Authors:
Wagner, Michael; Othus, Megan; Patel, Sandip; Ryan, Christopher; Sangal, Ashish; Powers, Benjamin; Budd, George; Victor, Adrienne; Hsueh, Chung-Tsen; Chugh, Rashmi; Nair, Suresh; Leu, Kirsten; Agulnik, Mark; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Blanke, Charles; Streicher, Howard; Chae,...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A843
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study. (20th August 2020)

Authors:
Riedel, Richard F.; Ballman, Karla V.; Lu, Yao; Attia, Steven; Loggers, Elizabeth T.; Ganjoo, Kristen N.; Livingston, Michael B.; Chow, Warren; Wright, Jennifer; Ward, John H.; Rushing, Daniel; Okuno, Scott H.; Reed, Damon R.; Liebner, David A.; Keedy, Vicki L.; Mascarenhas, Leo; Davis, Lara E.; ...
Journal:
Oncologist
Issue:
Volume 25:Number 11(2020)
Page Start:
e1655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗